Journal of Pharmacology and Therapeutic Research

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Journal of Pharmacology and Therapeutic Research 44 7897 074717

Free Glycomics Journals

 

The 26S proteasome may be a 2.5 MDa protein complex, which degrades unneeded and damaged proteins within the cell. As such, it's critical in regulating proteostasis and controls key regulator abundance levels. Malfunctioning of the ubiquitin–proteasome system has been implicated in diseases like cancer and neurodegenerative disorders. On the opposite hand, in cancer therapeutics the induction of apoptosis by proteasome inhibition using drugs is widely used. Current strategies are directed towards the event of more selective inhibitors that focus on the proteasome regulatory subcomplex and have less side-effects. We take a proteomics approach to dissect the molecular mechanisms of the proteasome regulatory subcomplex, which is important for the event of higher proteasome inhibitors. Targeted proteasome inactivation by selective RNAi knockdown or drugs is monitored at the proteome and ubiquitinome levels employing a SILAC approach in Drosophila. Over 5,000 proteins and 10,000 diGly peptides were identified and quantified. After brief inactivation by drugs, proteins involved in stress response, cell cycle regulation, apoptosis and therefore the UPS were upregulated (e.g., Hsp proteins) and accumulated. After prolonged inactivation, the abundances of several 100s of proteins were altered. Similar effects were observed after inactivation of the proteasome with RNAi knockdown of various subunits. Protein ubiquitination dramatically increased upon proteasome inactivation. Interestingly, many proteins showed dynamic ubiquitination changes in opposite directions on different target lysine residues within an equivalent protein. Proteomic analysis of individual RNAi knockdown of three proteasome bound deubiquitinating enzymes indicated that every of them features a different and specific function. Finally, proteasome interactome profiling under different experimental conditions using LFQ based quantitation suggested that the proteasome itself may be a dynamic complex that recruits different partners and/or (sub)complexes under specific conditions. Global analysis of the dynamic proteome and ubiquitinome after proteasome inactivation gives detailed insight into regulatory mechanisms of the proteasome.

High Impact List of Articles
Conference Proceedings

Relevant Topics in Medical Sciences

Get the App